6-Phenyl-4,5,6,7-tetrahydro-benzothiazol-2-ylamine, 1g

2-(Oxan-4-yl)pyridine, 99.0%, 1g

4-(1,4-diazepan-1-yl)butanenitrile, 95.0%, 1g

3-(4-Benzyloxy-3-methoxyphenyl)-4-benzyl-1,2,4-triazoline-5-thione, 95%, 1g

(1-Benzhydrylazetidin-2-yl)methanol, 98%, 100mg

HPLC column NUCLEODUR® NH2-RP 5 µm, 125 mm, 4 mm, 1 Piece(s)

4-PHENOXYANILINE, 95.0%, 500g

(2E)-1-(3-chlorophenyl)-3-(2-methoxyphenyl)prop-2-en-1-one, 95.0%, 2g

6-Fluoro-3-(4-(3-methoxy-4-(4-methyl-1H-imidazol-1-yl)phenyl)-1H-1,2,3-triazol-1-yl)-4,5-dihydro-1H-benzo[b]azepin-2(3H)-one, 97%, 50mg

1-(4-(Trifluoromethyl)pyridin-2-yl)piperidine-4-carboxylic acid, 98%, 250mg

[2-(4-methyl-1,3-thiazol-2-yl)ethyl]amine dihydrochloride, 95.0%, 2.5g

6-Chloro-4-hydroxyquinoline, 95.0%, 5g

2-Hydroxy-3,5-dimethyl-benzaldehyde, 95.0%, 5g